Michel T Corban Selected Research

Michel T Corban Research Topics

13	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 08/2012
6	Atherosclerosis 12/2021 - 06/2013
5	Stroke (Strokes) 01/2022 - 01/2020
5	Myocardial Infarction 12/2021 - 12/2018
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 03/2015
3	Heart Failure 01/2022 - 12/2018
3	Pathologic Constriction (Stenosis) 10/2020 - 01/2018
3	Diabetes Mellitus 10/2020 - 01/2020
3	Thrombosis (Thrombus) 01/2020 - 05/2017
2	Ischemia 01/2022 - 06/2013
2	Infarction (Infarctions) 01/2022 - 01/2020
2	Inflammation (Inflammations) 01/2021 - 07/2017
2	Chest Pain (Chest Pains) 10/2020 - 01/2020
2	ST Elevation Myocardial Infarction 01/2020 - 12/2018
2	Atherosclerotic Plaque (Atheroma) 01/2016 - 10/2012
1	Microvascular Angina (Cardiac Syndrome X) 01/2022
1	Dysbiosis 01/2021
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2021
1	Chronic Renal Insufficiency 10/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Neoplasms (Cancer) 01/2020
1	Rupture 01/2020
1	Hyperemia 01/2020
1	Hematoma 01/2019
1	Ventricular Tachycardia 12/2018
1	Autoimmune Diseases (Autoimmune Disease) 05/2017
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 05/2017
1	Venous Thromboembolism 05/2017

6	omega-Chloroacetophenone (Mace)IBA 12/2021 - 12/2018
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2020 - 10/2012
2	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2020 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2016 - 03/2015
1	OsteocalcinIBA 01/2021
1	trimethyloxamine (trimethylamine N-oxide)IBA 01/2021
1	Fibroblast Growth Factor-23IBA 01/2021
1	HomocysteineIBA 10/2020
1	HDL CholesterolIBA 10/2020
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2020
1	Vitamin B Complex (B Vitamins)IBA 10/2020
1	Triglycerides (Triacylglycerol)IBA 10/2020
1	LDL CholesterolIBA 10/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	SoilIBA 01/2020
1	Plasminogen InactivatorsIBA 01/2018
1	FibrinIBA 01/2018
1	LipidsIBA 07/2017
1	Antiphospholipid AntibodiesIBA 05/2017
1	Atenolol (Tenormin)FDA LinkGeneric 01/2016
1	Nebivolol FDA Link 01/2016
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2016
1	Urokinase Plasminogen Activator ReceptorsIBA 03/2015
1	Atorvastatin (Lipitor)FDA Link 10/2012
1	P 11 (P-11)IBA 10/2012
1	CalciumIBA 10/2012
1	Phenobarbital (Luminal)FDA Link 08/2012

7	Therapeutics 01/2022 - 10/2012
2	Transplantation 01/2022 - 12/2021
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022
1	Aftercare (After-Treatment) 01/2022
1	Myocardial Revascularization 01/2022
1	Catheter Ablation 01/2019
1	Percutaneous Coronary Intervention 12/2018
1	Stents 06/2013